Martinez J E, Barauna Filho I S, Kubokawa K, Pedreira I S, Machado L A, Cevasco G
Medical School of Sorocaba, Pontificia Universidade Católica de São Paulo, Brazil.
Disabil Rehabil. 2001 Jan 20;23(2):64-8.
The purpose of this study is to assess the impact of Fibromyalgia (FM) on the female patient's quality of life who attended the Rheumatology Outpatient Unit of Sorocaba Hospital Complex and compare it to the quality of life of healthy control group, through the Medical Outcome Study Short-form 36 item Survey (SF36).
32 women who fitted the American College of Rheumatology Classification Criteria for Fibromyalgia and 28 healthy women.
The groups were submitted to 'Medical Outcome Study 36 Item Short-form Survey' (SF36). This questionnaire is composed of 8 scales about several aspects of the quality of life.
The SF36 scales in the Fibromyalgia group presented the following results: general health--43.3; functional ability--39.4; bodily pain--26.5; physical functioning--14.8 (0-75); vitality--38.5 (5-85); emotional functioning--32.2; mental health--44.2; social functioning--45.1. The SF36 scales in the control group presented the following results: general health--73.2; functional ability--86.6; bodily pain--68.9; physical functioning--82.4; vitality--59.6; emotional functioning--78.5; mental health--67.4; social functioning--77.9. Significant statistics variations in all evaluated scales were presented by the survey group.
Fibromyalgia has had a negative impact on the quality of life.
本研究旨在通过医学结局研究简明36项调查问卷（SF36），评估在索罗卡巴综合医院风湿病门诊就诊的女性纤维肌痛（FM）患者的生活质量，并与健康对照组的生活质量进行比较。
32名符合美国风湿病学会纤维肌痛分类标准的女性和28名健康女性。
两组均接受“医学结局研究36项简明调查问卷”（SF36）。该问卷由8个关于生活质量多个方面的量表组成。
纤维肌痛组的SF36量表结果如下：总体健康——43.3；功能能力——39.4；身体疼痛——26.5；生理功能——14.8（0 - 75）；活力——38.5（5 - 85）；情感功能——32.2；心理健康——44.2；社会功能——45.1。对照组的SF36量表结果如下：总体健康——73.2；功能能力——86.6；身体疼痛——68.9；生理功能——82.4；活力——59.6；情感功能——78.5；心理健康——67.4；社会功能——77.9。调查显示，所有评估量表均存在显著统计学差异。
纤维肌痛对生活质量有负面影响。
